Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Biochemical and Biophysical Research Communications|May 1, 2017
Compound 21 and Telmisartan combination mitigates type 2 diabetic nephropathy through amelioration of caspase mediated apoptosisAnuradha Pandey, Anil Bhanudas Gaikwad
European Journal of Pharmacology|September 26, 2017
AT2 receptor agonist Compound 21: A silver lining for diabetic nephropathyAnuradha Pandey, Anil Bhanudas Gaikwad
Pharmacological Research|February 16, 2016
E3 ubiquitin ligases as novel targets for inflammatory diseasesSantosh Kumar Goru, Anuradha Pandey, Anil Bhanudas Gaikwad
Molecular Biotechnology|March 3, 2026
Molecular Characterization of OsHAD Phosphoprotein: Expression, Catalytic Properties, and Functional AnnotationAnuradha Pandey, Aparna Ramakrishnan, Raja Bhaiyya, et al.
Frontiers in Genome Editing|March 13, 2023
Genome editing for improving nutritional quality, post-harvest shelf life and stress tolerance of fruits, vegetables, and ornamentalsPunam Sharma, Anuradha Pandey, Rinku Malviya, et al.
CNS & Neurological Disorders Drug Targets|August 22, 2015
Nanoparticles: A Neurotoxicological PerspectiveAnuradha Pandey, Vajir Malek, Visakh Prabhakar, et al.
Indian Journal of Pharmacology|March 9, 2018
Telmisartan and esculetin combination ameliorates type 2 diabetic cardiomyopathy by reversal of H3, H2A, and H2B histone modificationsAlmesh Kadakol, Vajir Malek, Santosh Kumar Goru, et al.
Current Diabetes Reviews|August 5, 2015
FoxO1 Inhibitors: The Future Medicine for Metabolic Disorders?Anuradha Pandey, Goru Santosh Kumar, Almesh Kadakol, et al.
Pageof 3